International Nonproprietary Names for Pharmaceutical Substances (INN)...
January 01, 2001
|
ATC/DDD methodology: a country perspective.
January 01, 2001
|
Sarpogrelate: revised data sheet.
January 01, 2001
|
Rivastigmine: revised product information.
January 01, 2001
|
Monoethanolamine oleate: revised data sheet.
January 01, 2001
|
Mofezolac: revised data sheet.
January 01, 2001
|
Droperidol: prolongation of the QT interval.
January 01, 2001
|
Bufexamac and contact eczema.
January 01, 2001
|
Amfepramone: new cases of primary pulmonary hypertension.
January 01, 2001
|
SSRIs and increased ocular pressure.
January 01, 2001
|
Cerivastatin: rare effect of rhabdomyolysis.
January 01, 2001
|
Celecoxib and warfarin interaction.
January 01, 2001
|
Ergotamine and erythromycin interaction.
January 01, 2001
|
Tetracycline and benign intracranial hypertension.
January 01, 2001
|
Gentamicin ear drops: ototoxicity.
January 01, 2001
|
Anti-inflammatory analgesics: hepatic reactions.
January 01, 2001
|
New glucose test for adult diabetics.
January 01, 2001
|
Isotretinoin and depression.
January 01, 2001
|
Levacetylmethadol: labelling changes.
January 01, 2001
|
Levacetylmethadol withdrawn.
January 01, 2001
|
Rapacuronium bromide voluntarily withdrawn.
January 01, 2001
|
Leflunomide: hepatic reactions.
January 01, 2001
|
Propofol: not for paediatric use.
January 01, 2001
|
Propofol: reactions to long-term high doses.
January 01, 2001
|
Bupropion safety reminder.
January 01, 2001
|
New formulation of DTP vaccine.
January 01, 2001
|
China revises its pharmaceutical law.
January 01, 2001
|
Multilateral Initiative on Malaria: benefits to the global community.
January 01, 2001
|
Sequencing of the Anopheles gambiae genome.
January 01, 2001
|
The WHO Model List of Essential Drugs: latest developments.
January 01, 2001
|
Risk assessment as an element of drug control.
January 01, 2001
|
Good pharmaceutical trade and distribution practices.
January 01, 2001
|
